WSTAM
TECH icon

Wilbanks Smith & Thomas Asset Management’s Bio-Techne TECH Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-380
Closed -$19K – 1209
2018
Q3 		$19K Buy
+380
New +$16.8K ﹤0.01% 902

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's TECH Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Bio-Techne (TECH) in Q4 2018, closing a stake of 380 shares — an estimated $19K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in TECH in Q3 2018 and held it in 1 quarter. The position peaked at $19K in Q3 2018. 328 funds tracked by Wall St. Rank hold TECH as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Bio-Techne position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 380 Bio-Techne shares in Q4 2018, an estimated $19K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Bio-Techne in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Bio-Techne position peaked at $19K in Q3 2018.
  • 328 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.